...
首页> 外文期刊>British Journal of Cancer >First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer
【24h】

First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer

机译:上皮性卵巢癌女性中FGF-3(INT-2)扩增的首次经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Estimation of FGF-3 oncogene amplification in DNA samples extracted from paraffin embedded sections of 136 ovarian cancer samples was carried out by a quantitative PCR method. The aim of this study was to elucidate a possible association of FGF-3 copy numbers with established prognostic factors such as age, histology, FIGO stage, grading, postoperative residual tumour mass, ascites, hormone receptor content and preoperative CA 125 serum levels. In addition, correlation of FGF-3 amplification with overall survival of the patients was assessed. There was a borderline positive correlation between preoperative CA 125 serum levels and the degree of amplification of the FGF-3 gene (P = 0.06). A statistically significant association of FIGO-stage with FGF-3 copy number could be found (P = 0.008). No correlation between FGF-3 amplification and overall survival was noted. The data combine to suggest that FGF-3 is an indicator of aggressiveness of ovarian cancer.
机译:通过定量PCR方法对从136个卵巢癌样品的石蜡包埋切片中提取的DNA样品中的FGF-3癌基因扩增进行评估。这项研究的目的是阐明FGF-3拷贝数与已建立的预后因素如年龄,组织学,FIGO分期,等级,术后残余肿瘤量,腹水,激素受体含量和术前CA 125血清水平之间的可能联系。另外,评估了FGF-3扩增与患者总体存活率的相关性。术前CA 125血清水平与FGF-3基因扩增程度之间存在临界正相关(P = 0.06)。可以发现FIGO-阶段与FGF-3拷贝数具有统计学意义的关联(P = 0.008)。没有发现FGF-3扩增与总生存之间的相关性。数据综合表明,FGF-3是卵巢癌侵袭性的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号